MBS Item 14206 covers the insertion of hormone or living tissue implants using a cannula. Common examples include Implanon, a contraceptive implant, and Zoladex, a hormone therapy implant used for prostate cancer treatment. This item is often paired with MBS 30062 for implant removal, making it essential for procedures where one implant is replaced with another.
Key Considerations for MBS Item 14206
1. Independent Procedure Requirement
- A new implant must be inserted into a separate excision site from where the previous implant was removed.
- This ensures compliance with Medicare’s requirement that the removal and insertion are documented as separate, independent procedures.
2. Common Scenarios for MBS 14206
- Contraceptive Implants: Removing and replacing an Implanon implant.
- Hormone Therapy: Inserting Zoladex implants for conditions like prostate cancer treatment.
3. Documentation and Patient Care
- Patient Consent: Explain the procedure to the patient and obtain their consent.
- Thorough Documentation: Record all aspects of the procedure, including details of the new excision site and the reasons for implant replacement.
Conclusion
MBS Item 14206 plays a crucial role in procedures involving hormone and tissue implants by ensuring proper insertion protocols and compliance with Medicare requirements. By following the guidelines for independent procedures, clear documentation, and patient care, GPs can provide safe, effective treatment while optimising their billing processes.
.png)
.png)